Chief Financial Officer (CFO)
Mr. Edmund Hen
Chief Financial Officer (CFO) of
YD Biopharma
Mr. Edmund Hen is an experienced financial executive with over two decades of expertise in corporate finance, capital markets, and business strategy. As Chief Financial Officer (CFO) at YD Biopharma, he brings extensive knowledge in financial management, regulatory compliance, and business development. His leadership has been instrumental in supporting the company’s growth initiatives and expanding its market presence.
“At YD Biopharma, we recognize that sound financial stewardship is essential for driving sustainable growth. Through collaboration, innovation, and disciplined financial strategy, we are committed to advancing our mission and delivering long-term value to patients and stakeholders.”

Academic Excellence
Master of Science in Professional Accounting, University College London, UK
Bachelor of Science in Accounting and Finance, University of East Anglia, UK

Professional Achievements
Led the IPO process for several companies, including roadshows, secondary offerings, and bond offerings.
Oversaw the resolution of halted stock trading and legal class actions, maintaining investor confidence.
Managed M&A activities, investor relations, and corporate finance for companies listed on U.S. and international capital markets.
Instrumental in expanding companies’ operations across multiple regions, including China and Southeast Asia.
